Product
Cabergoline
Aliases
Cabergoline 0.5 MG, Cabergoline 1 MG, Dostinex
Name
Cabergoline
INN Name
Cabergoline
FDA Approved
Yes
7 clinical trials
8 organizations
6 indications
1 document
Indication
agalactiaIndication
MigraineIndication
Polycystic Ovary SyndromeIndication
Health EducationIndication
EndometriosisIndication
Second Trimester AbortionClinical trial
Cabergoline for Lactation Inhibition After Early Second-Trimester Abortion or Pregnancy Loss: A Randomized Controlled TrialStatus: , Estimated PCD: 2025-12-01
Clinical trial
Cabergoline as a Preventive Treatment for Chronic Migraine: an Investigator-Initiated, Randomized Clinical TrialStatus: Completed, Estimated PCD: 2023-06-13
Clinical trial
Effects of Combined Metformin and Cabergoline in Comparison With Metformin Only Therapy on Ovarian and Hormonal Activities in Iraqi Patients With PCOSStatus: Completed, Estimated PCD: 2023-03-31
Clinical trial
Cabergoline for Lactation Inhibition After Second-Trimester Abortion or LossStatus: Completed, Estimated PCD: 2022-06-24
Clinical trial
Clinical Guidance to Increase Women's Awareness of Some Contributing Factors to Help Proper Treatment of Unexplained Resistant Hyperprolactinemia Not Responding to Therapeutic Dopamine Agonists (DA)Status: Completed, Estimated PCD: 2023-01-05
Clinical trial
Novel, Non-Hormonal Therapy for the Treatment of Chronic Pain Due to Endometriosis in Adolescent and Adult WomenStatus: Recruiting, Estimated PCD: 2026-06-01
Clinical trial
Pharmacological Inhibition of Lactation After 16 to 20 Week Abortion: a Randomized Controlled TrialStatus: Recruiting, Estimated PCD: 2024-06-30
Document
DailyMed Label: CabergolineOrganization
A-S Medication SolutionsOrganization
Greenstone LLCOrganization
Ingenus Pharmaceuticals, LLCOrganization
SOLA Pharmaceuticals, LLCOrganization
Teva Pharmaceuticals USA, Inc.Organization
SKG Pharma Inc.Organization
Strides Pharma Science Limited